Bacterial peptidoglycan D-Ala-D-Ala precursors — Drug Target

All drugs that target Bacterial peptidoglycan D-Ala-D-Ala precursors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Glycopeptide antibiotic

Phase 3 pipeline (1)

• Prophylactic Vancomycin · Memorial Sloan Kettering Cancer Center · Glycopeptide antibiotic · Oncology / Infectious Disease Prevention
  Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala peptidoglycan precursors, preventing cross-linking and causing cell wall disruption.